GNMSF - Genmab's (GNMSF) CEO Jan van de Winkel on Q1 2018 Results - Earnings Call Transcript
Genmab A/S (GNMSF)
Q1 2018 Earnings Conference Call
May 8, 2018 12:00 PM ET
Executives
Jan van de Winkel — President and Chief Executive Officer
David Eatwell — Chief Financial Operator
Analysts
Michael Novod — Nordea
James Quigley — JPMorgan
Wimal Kapadia — Bernstein
Peter Welford — Jefferies
Peter Sehested — Handelsbanken
Anastasia Karpova — Kempen
Peter Verdult — Citi
Frank Anderson — Jyske Bank
Presentation
Operator
Good day, and welcome to the Genmab Q1 Reports 2018 Conference Call. Today’s conference is being recorded. During this telephone conference, you may be presented with forward-looking statements